Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network

被引:101
作者
Kapral, MK
Laupacis, A
Phillips, SJ
Silver, FL
Hill, MD
Fang, JM
Richards, J
Tu, JV
机构
[1] Inst Clin Evaluat Sci, Toronto, ON, Canada
[2] Univ Hlth Network, Div Gen Internal Med, Toronto, ON, Canada
[3] Univ Hlth Network, Clin Epidemiol & Womens Hlth Program, Toronto, ON, Canada
[4] Sunnybrook & Womens Coll Hlth Sci Ctr, Clin Epidemiol & Hlth Care Res Program, Toronto, ON, Canada
[5] Sunnybrook & Womens Coll Hlth Sci Ctr, Div Gen Internal Med, Toronto, ON, Canada
[6] Univ Hlth Network, Div Neurol, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
[8] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
[9] Dalhousie Univ, Div Neurol, Halifax, NS, Canada
[10] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada
[11] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada
[12] Univ Calgary, Dept Med, Calgary, AB, Canada
[13] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada
关键词
stroke; quality of health care;
D O I
10.1161/01.STR.0000130423.50191.9f
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-Guidelines and performance indicators have been established for acute stroke care. However, little is known about the process of stroke care delivery in Canada. Methods-The Registry of the Canadian Stroke Network (RCSN) captured detailed clinical data on patients with stroke and transient ischemic attack seen at 21 acute care institutions across Canada. Data from phase 1 of the RCSN (June 2001 to February 2002) were used to determine the use of evidence-based acute stroke care interventions in participating institutions. Results-Overall, 4439 patients were seen during the study time frame and 1701 (38%) consented to full data collection. Thirty-one percent received care on a stroke unit or from a mobile stroke team. Among patients with ischemic stroke, 7% received thrombolysis, 80% underwent carotid imaging, 89% received antithrombotic agents, and 54% of those with atrial fibrillation received warfarin. There were significant intersite variations in the delivery of all of these interventions except for the use of antithrombotic agents, and these persisted after adjustment for age, sex, stroke type, and other comorbid conditions. Conclusions-Patients in institutions participating in the RCSN received high-quality stroke care based on a number of performance measures. However, gaps exist in the provision of other elements of stroke care, particularly organized inpatient stroke care and warfarin for atrial fibrillation. Future research should explore explanations for these findings and focus on solutions to deficiencies in care.
引用
收藏
页码:1756 / 1762
页数:7
相关论文
共 43 条
  • [1] Antithrombotic therapy in atrial fibrillation
    Albers, GW
    Dalen, JE
    Laupacis, A
    Manning, WJ
    Petersen, P
    Singer, DE
    [J]. CHEST, 2001, 119 (01) : 194S - 206S
  • [2] Recommendations for the establishment of primary stroke centers
    Alberts, MJ
    Hademenos, G
    Latchaw, RE
    Jagoda, A
    Marler, JR
    Mayberg, MR
    Starke, RD
    Todd, HW
    Viste, KM
    Girgus, M
    Shephard, T
    Emr, M
    Shwayder, P
    Walker, MD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (23): : 3102 - 3109
  • [3] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [4] CLASSIFICATION AND NATURAL-HISTORY OF CLINICALLY IDENTIFIABLE SUBTYPES OF CEREBRAL INFARCTION
    BAMFORD, J
    SANDERCOCK, P
    DENNIS, M
    BURN, J
    WARLOW, C
    [J]. LANCET, 1991, 337 (8756) : 1521 - 1526
  • [5] Improvement in stroke quality management by an educational programme
    Behrens, S
    Daffertshofer, M
    Interthal, C
    Ellinger, K
    van Ackern, K
    Hennerici, M
    [J]. CEREBROVASCULAR DISEASES, 2002, 13 (04) : 262 - 266
  • [6] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [7] Indications for early aspirin use in acute ischemic stroke - A combined analysis of 40 000 randomized patients from the Chinese Acute Stroke Trial and the International Stroke Trial
    Chen, ZM
    Sandercock, P
    Pan, HC
    Counsell, C
    Collins, R
    Liu, LS
    Xie, JX
    Warlow, C
    Peto, R
    [J]. STROKE, 2000, 31 (06) : 1240 - 1249
  • [8] Intravenous tissue plasminogen activator for acute ischemic stroke: Feasibility, safety, and efficacy in the first year of clinical practice
    Chiu, D
    Krieger, D
    Villar-Cordova, C
    Kasner, SE
    Morgenstern, B
    Bratina, PL
    Yatsu, FM
    Grotta, JC
    [J]. STROKE, 1998, 29 (01) : 303 - 303
  • [9] Warfarin for stroke prevention still underused in atrial fibrillation - Patterns of omission
    Cohen, N
    Almoznino-Sarafian, D
    Alon, I
    Gorelik, O
    Koopfer, M
    Chachashvily, S
    Shteinshnaider, M
    Litvinjuk, V
    Modai, D
    [J]. STROKE, 2000, 31 (06) : 1217 - 1222
  • [10] Duffy BK, 2003, MED J AUSTRALIA, V178, P318, DOI 10.5694/j.1326-5377.2003.tb05221.x